drugset / Trial / NCT04333654

Hydroxychloroquine in Outpatient Adults With COVID-19

NCT04333654

Phase 1 Terminated 8 enrolled Sanofi
RandomizedParallel-groupQuadruple-blindTreatment

Summary

Primary Objective: To assess the effect of hydroxychloroquine versus placebo on nasopharyngeal SARS-CoV-2 viral load in outpatient adults with COVID-19 Secondary Objectives: * To assess the effect of hydroxychloroquine versus placebo on clinical signs and symptoms and progression of disease in outpatient adults with COVID-19 * To assess the safety and tolerability of hydroxychloroquine in outpatient adults with COVID-19

Timeline

Start
2020-04-12
Primary completion
2020-05-26
Completion
2020-05-26

Drugs

EvaluationDrugModalityDoseRoute
Subject Hydroxychloroquine Small molecule Oral

Indications